ArticleClinical kidney journal2025

Glucagon-like peptide-1 receptor agonist therapy in patients with type 2 diabetes and advanced CKD: kidney and cardiovascular outcomes in a real-world setting.

Ching-Chung Hsiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.